OCTOPOD-IP is being conducted to investigate intraperitoneal (IP) administration of THEO-260 in women with advanced platinum-resistant ovarian ...
Evaluation of a Pharmacist-Led Medication Assessment Used to Identify Prevalence of and Associations With Polypharmacy and Potentially Inappropriate Medication Use Among Ambulatory Senior Adults With ...
Intraperitoneal Therapy Superior to multiple insulin injections in Early Diabetic Nephropathy: Study
Researchers have found in a new study that Intraperitoneal (IP) therapy demonstrated better efficacy than MSII in improving ...
Please provide your email address to receive an email when new articles are posted on . The addition of intraperitoneal paclitaxel to systemic capecitabine and oxaliplatin appeared to benefit patients ...
In clinical practice, only a few risk factors remain that can be modified based on the decisions of patients and their physicians. The surgical decision making and chemotherapy administration choices, ...
Cancers originating from organs in the peritoneal cavity (e.g., ovarian, pancreatic, colorectal, gastric and liver) account for approximately 250,000 new cancer cases annually in the USA. Peritoneal ...
WEST PHILADELPHIA (WPVI) -- Chemotherapy is a lifesaver in cancer treatment. But an IV isn't always the best way to deliver it. A different technique is helping make a difference for some abdominal ...
Please provide your email address to receive an email when new articles are posted on . Adding hyperthermic intraperitoneal chemotherapy to cytoreductive surgery did not significantly prolong PFS or ...
HIPEC surgery is a promising treatment option for patients with certain abdominal cancers. Surgical oncologist Erin Ward, MD, discusses which patients would be best candidates for HIPEC, explains why ...
Peritoneal carcinomatosis (PC) of colorectal cancer (CRC) origin is associated with poor outcome. This systematic review evaluates the available evidence about adjuvant (hyperthermic) intraperitoneal ...
Based on the aforementioned PK/PD considerations, we elected a particle size of 4–6 µm to retard the lymphatic clearance and to promote distribution within the peritoneal cavity. TPMs have several ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results